The global critical limb ischemia treatment market is witnessing substantial growth due to the increasing prevalence of peripheral artery disease (PAD), diabetes, obesity, and cardiovascular disorders worldwide. Critical limb ischemia (CLI) is considered the most severe form of peripheral artery disease and requires immediate medical intervention to prevent tissue loss and amputation. Rising...